News
-
AI Medical Service Inc. receives manufacturing and marketing approval in Japan for Endoscopic Image Diagnosis Support Software “gastroAI model-G3”
-
AI Medical Service Inc. Recognized as a Winner at CHISEL Healthcare InnoMatch 2025 in Singapore
-
AI Medical Service Inc. has obtained regulatory approval from Thailand’s FDA for its gastric AI-based endoscopic diagnosis support system
-
AI Medical Service Wins METI Minister’s Award at GHeC, a Symposium and Business Contest for Healthcare Startups
-
AI Medical Service Appoints Former Executive Vice President of Boston Scientific Japan, Yasushi Takigawa, as New President — Transition to New Joint Management Structure
-
AI Medical Service Inc. Announces the Release of “Article Collection: Artificial Intelligence in Gastroenterology,” Co-Edited by CEO Dr. Tomohiro Tada
-
【Expo 2025 Osaka, Kansai, Japan】 AI Medical Service to Exhibit at “Next-Generation Medical Equipment Experience Corner”
-
Forbes Web published an interview with CEO Tada.
-
AI Medical Service Inc. Announces Regulatory Approval of Gastric AI-based Endoscopic Imaging Diagnostic Support System
-
TIME Magazine published an interview with CEO Tada.
-
AI Medical Service has been selected for the “Forbes Asia 100 To Watch 2024”
-
AI Medical Service Inc. Completes First Pharmaceutical Registration of Gastric AI-based Endoscopic Diagnosis Support System from Brazil’s ANVISA
-
AI Medical Service Inc. Signs Joint Research Agreement with Mahidol University in Thailand
-
AI Medical Service Inc. Announces Release of Gastric AI-based Endoscopic Diagnosis Support System
-
AI Medical Service Inc. Completes First Regulatory Review and Device Registration of Gastric AI-based Endoscopic Diagnosis Support System from Singapore’s HSA
-
AI Medical Service Inc. Announces Regulatory Approval of Gastric AI-based Endoscopic Diagnostic Imaging Support System
-
AI Medical Service Inc. Signs Joint Research Agreement with Leading Vietnamese Medical Institution
-
AI Medical Service Inc. Signs Joint Research Agreement with US Leading Cancer Institution
-
AI Medical Service Inc. Signs Joint Research Agreement with Stanford Medicine
-
AI Medical Service Inc. and Hospices Civils de Lyon (HCL) Begin Company-first European Collaborative Research on Gastric Endoscopic AI
-
AI Medical Service Inc. Signs Joint Research Agreement with The Chinese University of Hong Kong
-
AI Medical Service Inc. Relocates its Singapore Office to the NUHS Center for Innovation in Healthcare (CIH), strengthening ties with National University Hospital
-
AI Medical Service Inc. Acquires ISO 13485 Certification, an international standard for quality management systems (QMS) specific to the medical device industry
-
AI Medical Service Inc. Establishes US Second Base
-
CEO Dr. Tada Spoke at the Stanford Gastric Cancer Summit
-
AIM Establishes local subsidiary in Singapore
-
AI Medial Service Inc. Announces ¥8 Billion (US$70M) Series C Financing Led by SoftBank Vision Fund 2 (SVF2)
-
AIM Establishes U.S. subsidiary in Silicon Valley as a first overseas branch
-
AIM Applies for Approval to Manufacture and Market the World's First Gastric Cancer AI
-
Awarded as Technology Pioneer by World Economic Forum
-
AIM and Singapore’s National University Hospital Sign Joint Research Agreement on Endoscopic AI
-
AI Medical Service Inc. announces FDA Breakthrough Device Designation for endoscopic AI system